These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 4988692)

  • 21. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
    DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O
    Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plague.
    Williamson ED
    Vaccine; 2009 Nov; 27 Suppl 4():D56-60. PubMed ID: 19837288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects for new plague vaccines.
    Feodorova VA; Corbel MJ
    Expert Rev Vaccines; 2009 Dec; 8(12):1721-38. PubMed ID: 19943765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience using fraction I of the plague microbe for revaccinating experimental animals].
    Lebedinskiĭ VA; Chicherin IuV; Pautov VN; Evstigneev VI; Byvalov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):60-3. PubMed ID: 7102182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavior in vivo of strains of Pasteurella pestis in relation to their efficacy as live vaccines].
    Markenson J; Ben-Efraim S
    Ann Inst Pasteur (Paris); 1969 Aug; 117(2):196-212. PubMed ID: 5406056
    [No Abstract]   [Full Text] [Related]  

  • 27. STUDIES ON IMMUNIZATION AGAINST PLAGUE. XVII. EXPERIMENTAL STUDIES ON THE EFFECTIVENESS OF ALUMINUM-HYDROXIDE-ADSORBED FORMALIN-KILLED PASTEURELLA PESTIS.
    CHEN TH; LARSON A; MEYER KF
    J Immunol; 1964 Oct; 93():668-76. PubMed ID: 14219083
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of serological and bacteriological methods in the confirmation of plague infections.
    Legters LJ; Cottingham AJ; Hunter DG
    Bull World Health Organ; 1969; 41(6):859-63. PubMed ID: 5309534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of a recombinant F1-V fusion protein vaccine intended to protect Canada lynx (Lynx canadensis) from plague.
    Wolfe LL; Shenk TM; Powell B; Rocke TE
    J Wildl Dis; 2011 Oct; 47(4):888-92. PubMed ID: 22102659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plague Vaccines: Status and Future.
    Sun W
    Adv Exp Med Biol; 2016; 918():313-360. PubMed ID: 27722869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of the passive hemagglutination test in the study of immunologic reorganization with regard to plague under experimental conditions].
    Pilipenko VG; Oganian EF
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Mar; 45(3):26-31. PubMed ID: 5729695
    [No Abstract]   [Full Text] [Related]  

  • 33. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
    Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.
    Fellows P; Price J; Martin S; Metcalfe K; Krile R; Barnewall R; Hart MK; Lockman H
    Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylactic use of ceftriaxone in combination with F I antigen immunization in studies on uninbred albino mice infected by Yersinia pestis. Antiplague immunity development].
    Ryzhko IV; Moldavan IA; Tsuraeva RI; Shcherbaniuk AI
    Antibiot Khimioter; 2006; 51(9-10):8-12. PubMed ID: 18030785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of the effectiveness of different methoods of immunization with live plague vaccine EB in aerosol infections].
    Lebedinskiĭ VA; Chicherin IuV; Evstigneev VI; Paramonov VE; Timofeev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Sep; (9):11-4. PubMed ID: 115183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs.
    Meyer KF; Smith G; Foster L; Brookman M; Sung M
    J Infect Dis; 1974 May; 129():Suppl:S85-12. PubMed ID: 4207627
    [No Abstract]   [Full Text] [Related]  

  • 39. Plague.
    Titball RW; Leary SE
    Br Med Bull; 1998; 54(3):625-33. PubMed ID: 10326289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some characteristics of the plasmocytic reaction in Macaccus rhesus monkeys vaccinated with live plague vaccine (EV strain)].
    Durikhin KV; Zaplatina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1971; 48(6):135-40. PubMed ID: 4998905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.